AMVAD adjuvant for mucosal vaccines (L-11561) .: NR16-173/2017E-PDF
“The NRC has developed a novel archaeal polar lipid mucosal vaccine adjuvant and delivery (AMVAD) platform capable of generating mucosal and systemic immune responses against a wide range of pathogens that infect mucosal surfaces or use them to gain entry to the body”--Highlights, p. [1].
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.847520&sl=0
| Department/Agency | National Research Council Canada. |
|---|---|
| Title | AMVAD adjuvant for mucosal vaccines (L-11561) . |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Adjuvant AMVAD pour vaccins muqueux (L-11561). Caption title. "January 2017." Issued also in print format. |
| Publishing information | [Ottawa] : National Research Council Canada, [2018] |
| Description | [2] p. : ill. |
| ISBN | 9780660239385 |
| Catalogue number |
|
| Subject terms | Immunological adjuvants Liposomes |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: